Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Evvy’s new UTI+ Test and microbiome tools deliver faster, clearer insights into BV and UTI care, reshaping women’s health ...

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...

The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...

Simu Liu is an unwitting double agent in the first trailer for the high-tech spy series The Copenhagen Test. Watch the ...

The Sandiganbayan has upheld its earlier resolution allowing the withdrawal of the Pharmally cases for review and possible refiling by the Office of the Ombudsman.

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Global Influenza Diagnostics Market OverviewThe global influenza diagnostics market is projected to expand at a CAGR of 5–8% over the next five years. Market growth is fueled by the rising prevalence ...

At the meeting, researchers shared real-world data showing ctDNA positivity at the end of treatment was prognostic across lymphoma subtypes and better than PET scans.

OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing ...